Research shows a cause of gastrointestinal symptoms in Type 1 diabetes
Excess of growth factor binding protein damages colon-maintaining stem cells
Franco Folli, M.D., Ph.D., professor of medicine in the Diabetes Division of the School of Medicine at The University of Texas Health Science Center at San Antonio, is co-author on the findings. The studies were carried out by researchers at Boston Children's Hospital and Harvard Medical School in Boston and San Raffaele Hospital in Milan, Italy, led by Paolo Fiorina, M.D., Ph.D.
"Intestinal tissues from diabetic patients and healthy individuals were compared," Dr. Folli said. "In patients with Type 1 diabetes, the cell lining of the intestine was damaged. The stem cells that maintain this lining, called colonic stem cells, were altered. The culprit is found in a protein called insulin-like growth factor binding protein 3 (IGFBP3), which is produced in the liver and in higher amounts in type 1 diabetes. IGFBP3 binds to a receptor protein on colonic stem cells causing their death and, in turn, damaging the intestinal lining."
The team also experimented with a biopharmaceutical that blocks circulating levels of the protein. Studies in diabetic mice show that the drug can reverse the colon damage.
"This is a very exciting finding, obtained by studying patients' cells, that has the potential to result in a new treatment for this chronic complication of longstanding Type 1 diabetes," Dr. Folli said.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.